» Articles » PMID: 21893101

Virostatic Potential of Micro-nano Filopodia-like ZnO Structures Against Herpes Simplex Virus-1

Overview
Journal Antiviral Res
Publisher Elsevier
Date 2011 Sep 7
PMID 21893101
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Herpes simplex virus type-1 (HSV-1) entry into target cell is initiated by the ionic interactions between positively charged viral envelop glycoproteins and a negatively charged cell surface heparan sulfate (HS). This first step involves the induction of HS-rich filopodia-like structures on the cell surface that facilitate viral transport during cell entry. Targeting this initial first step in HSV-1 pathogenesis, we generated different zinc oxide (ZnO) micro-nano structures (MNSs) that were capped with multiple nanoscopic spikes mimicking cell induced filopodia. These MNSs were predicted to target the virus to compete for its binding to cellular HS through their partially negatively charged oxygen vacancies on their nanoscopic spikes, to affect viral entry and subsequent spread. Our results demonstrate that the partially negatively charged ZnO-MNSs efficiently trap the virions via a novel virostatic mechanism rendering them unable to enter into human corneal fibroblasts - a natural target cell for HSV-1 infection. The anti-HSV-1 activity of ZnO MNSs was drastically enhanced after creating additional oxygen vacancies under UV-light illumination. Our results provide a novel insight into the significance of ZnO MNSs as the potent HSV-1 inhibitor and rationalize their development as a novel topical agent for the prevention of HSV-1 infection.

Citing Articles

The Impact of an MDP-Containing Primer on the Properties of Zinc Oxide Networks Infiltrated with BisGMA-TEGDMA and UDMA-TEGDMA Polymers.

Wellhausser B, Saure L, Schutt F, Scherer F, Wille S, Kern M Materials (Basel). 2025; 18(1.

PMID: 39795782 PMC: 11721492. DOI: 10.3390/ma18010137.


Progress and Perspective of Antiviral Protective Material.

Zhou J, Hu Z, Zabihi F, Chen Z, Zhu M Adv Fiber Mater. 2024; 2(3):123-139.

PMID: 38624352 PMC: 7309218. DOI: 10.1007/s42765-020-00047-7.


Antiviral activity of zinc against hepatitis viruses: current status and future prospects.

Kumar S, Ansari S, Narayanan S, Ranjith-Kumar C, Surjit M Front Microbiol. 2023; 14:1218654.

PMID: 37908540 PMC: 10613677. DOI: 10.3389/fmicb.2023.1218654.


Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry.

Elste J, Kumari S, Sharma N, Razo E, Azhar E, Gao F Int J Mol Sci. 2023; 24(19).

PMID: 37834240 PMC: 10573121. DOI: 10.3390/ijms241914792.


Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves.

Rahman A, Roy K, Deb G, Ha T, Rahman S, Aktar M Int J Mol Sci. 2023; 24(17).

PMID: 37685938 PMC: 10488153. DOI: 10.3390/ijms241713130.


References
1.
Liu J, Thorp S . Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev. 2001; 22(1):1-25. DOI: 10.1002/med.1026. View

2.
Shukla D, Liu J, Blaiklock P, Shworak N, Bai X, Esko J . A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 1999; 99(1):13-22. DOI: 10.1016/s0092-8674(00)80058-6. View

3.
ODonnell C, Shukla D . The Importance of Heparan Sulfate in Herpesvirus Infection. Virol Sin. 2009; 23(6):383-393. PMC: 2778322. DOI: 10.1007/s12250-008-2992-1. View

4.
Tiwari V, Clement C, Duncan M, Chen J, Liu J, Shukla D . A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. J Gen Virol. 2004; 85(Pt 4):805-809. DOI: 10.1099/vir.0.19641-0. View

5.
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View